Discover how urine biopsy offers a less invasive and more accurate method for detecting bladder, kidney, and prostate cancers ...
A second prostate-specific membrane antigen (PSMA) PET scan changed treatment plans for nearly half of patients whose first ...
The Stockholm3 model combines PSA, plasma protein biomarkers, polygenic risk, and clinical factors for prostate cancer screening.
Researchers at the University of British Columbia have identified a new form of hereditary prostate cancer that, while rare, ...
September marks the beginning of National Prostate Cancer Awareness Month in the United States, and statistics show that one ...
Researchers at the University of British Columbia have identified a new form of hereditary prostate cancer that, while rare, ...
Morning Overview on MSN
The FDA cleared its first blood test to flag prostate cancer in men with high PSA
An elevated PSA reading has long put men in an uncomfortable position: it signals possible prostate cancer, but it is ...
A second scan using prostate-specific membrane antigen positron emission tomography changed treatment plans for nearly half of patients with recurrent prostate cancer whose initial scan was negative, ...
Tuko News on MSN
Anyang' Nyong'o opens up on 15-year prostate cancer journey, launches mobile screening clinic
Kisumu governor Anyang' Nyong'o marks 15 years since his prostate cancer diagnosis and launches a mobile clinic to expand ...
Morning Overview on MSN
A blood test caught 90% of aggressive prostate cancers, against 74% for the standard PSA
The standard PSA test has anchored prostate cancer screening for decades, but it has a well-known weakness: it flags plenty ...
It's important to share any health changes with your doctor.
An AI-powered biomarker based on histology alone predicted survival among men with metastatic hormone-sensitive prostate cancer and identified those who benefitted from escalation to triplet therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results